Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.

The Lancet. Infectious diseases - 1 Nov 2016

Inzaule Seth C, Ondoa Pascale, Peter Trevor, Mugyenyi Peter N, Stevens Wendy S, de Wit Tobias F Rinke, Hamers Raph L

Abstract excerpt

Increased provision of antiretroviral therapy in sub-Saharan Africa has led to a growing number of patients with therapy failure and acquired drug-resistant HIV, driving the demand for more costly further lines of antiretroviral therapy. In conjunction with accelerated access to viral load monitoring, feasible and affordable technologies to detect drug-resistant HIV could help maximise the durability and rational...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Africa South of the Sahara
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Mass Screening

Share to Viral Load

Source

Identifiers

PMID: 27569762
DOI: 10.1016/S1473-3099(16)30118-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.PMID 27569762Read ↗

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.Semantic proximity Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.Semantic proximity Read ↗

MARVEL-minimising the emergence and dissemination of HIV-1 drug resistance in Portuguese-speaking African Countries (PALOP): low-cost portable NGS platform for HIV-1 surveillance in Africa.Semantic proximity Read ↗

Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countriesSemantic proximity Read ↗

Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.Semantic proximity Read ↗

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.Semantic proximity Read ↗

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan womenSemantic proximity Read ↗

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.Semantic proximity Read ↗

Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.Semantic proximity Read ↗

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Semantic proximity Read ↗

Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.